3Fang PC, Yen YK, Yu CC,et al. Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan [ J]. Journal of Ethnopharmcology,2008, 117 : 84.
4Shu CH,Jung NL, Chuan FL,et al. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database[J]. Pharmacoepidemiology and Drug Safety, 2008,17:609.
5Chou HC, Cheng CH, Chang JR. Extracting drug utilization knowledge using self-organizing map and rough set theory[ J]. Expert Systems with Applications,2007,33:499.
6Patricia BC. Choice of antibiotic in open heart surgery[ J]. Intelligent Decision Technologies,2007,1:63.
7Emanud R, Elusabetta P, Chlavra Z,et al. Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period [ J]. British Journal of Clinical Pharmacology, 2008,1:88.
8Monnet DL, Lopez JM, Campillos P,et al. Making sense of antimicrobial use and resistance surveillance data: application of ARI- MA and transfer function models [ J]. Clin Microbiol Infect. 2001 ;7 ( Suppl 5 ) :29.
9Fridkin SK, Lawton R, Edwards JR, et al. Monitoring antimicrobial use and resistance : comparison with a national benchmark on reducing vancomycin use and vanconlycin-resistant enterococci [ J ]. Emerg Infect Dis, 2002,8 (7) :702.
10Gordon D, David K, Josh P,et al. Linking laboratory and pharmacy, opportunities for reducing errors and improving care [ J]. Arch Intern Med. 2003,163:893.
